Exhausted by Shoulder Pain?

Rotator cuff tendinopathy, or ‘RCT', can have a profound impact on daily life. Individuals are often expected to just live with the pain, but symptoms can have a serious effect on sleep and ability to do day-to-day tasks such as housework or even eating a meal.

​

Current standard of care treatments, including nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or aspirin, only address the symptoms rather than treating the condition. That’s why we’re running a clinical trial to see if an investigational drug can help improve physical shoulder function and reduce pain in people with RCT.

 

WHO CAN TAKE PART?

​

To be eligible, in addition to other criteria, you must:

​

• Be between 18 and 65 years old

• Have experienced symptoms of RCT in the past 6 months

• (MRI) scan to confirm RCTUndergo a magnetic resonance imaging

• Not be diagnosed with any of the following conditions: fibromyalgia, gout, psoriasis, rheumatoid arthritis, or tuberculosis

​​

WHAT WILL HAPPEN IF I TAKE PART?

If you are eligible and choose to participate, you’ll need to attend approximately 10 to 12 clinic visits over 32 weeks. This is so the trial team can monitor your health. During this time, you’ll have a 1 in 2 chance of being randomly assigned to receive either the investigational drug or a placebo. You’ll receive your trial drug as a subcutaneous (under the skin) injection every week for the first month, then every 4 weeks.